Download Our DHN Survey Result 2024
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Mandaviya Invites Japanese Medical Device Makers to Leverage Make in India Initiative

Written by : Aishwarya Sarthe

June 9, 2023

Category Img

The Indian government approved its first National Medical Devices Policy, which identified six strategies for strengthening this sector.

During his visit to Tokyo, Union Health Minister Mansukh Mandaviya urged Japanese medical device manufacturers to take advantage of the opportunities presented by the Indian government's "Make in India" initiative. Addressing representatives from Japanese firms, Mandaviya highlighted that India allows 100% foreign direct investment (FDI) under the automatic route for both greenfield and brownfield projects, aiming to attract global investors. He emphasized the crucial role of the medical devices sector in India's healthcare industry.

image credit- PIB

Mandaviya acknowledged the significant contribution of the medical devices sector in India, particularly during the COVID-19 pandemic. India played a crucial role in the domestic and global battle against the virus by ramping up production of medical devices and diagnostic kits. He invited Japanese firms to participate in the "Make in India," "Innovate in India," and "Discover in India" initiatives, emphasizing the potential for growth and collaboration.

Union Health Minister Mansukh Mandaviya has set an ambitious target for India's medical devices sector, aiming for a four-fold growth to reach $44 billion by 2030. Currently valued at $11 billion, this expansion reflects Mandaviya's confidence in India's potential to emerge as a prominent global player in medical device manufacturing and innovation. This vision aligns with the country's objectives during its G20 presidency.

To boost domestic manufacturing, the Indian government introduced the Production Linked Incentive Schemes for medical devices, which offer financial incentives worth $400 million. Mandaviya also announced the approval of four Medical Device Parks to reduce manufacturing costs and provide easy access to standardized testing and infrastructure facilities.

India recently approved its first National Medical Devices Policy, which outlines six strategies to strengthen the industry. Mandaviya highlighted the importance of this policy in fostering a conducive environment for medical device manufacturing and innovation. He also announced plans for a proposed National Policy on Research and Development (R&D) and Innovation in the Pharma-MedTech sector, aiming to facilitate strong collaborations and translational research.

The Indian government's initiatives and policies demonstrate its dedication to fostering the expansion of the medical devices sector and positioning India as a global center for manufacturing and innovation. Through its invitation to Japanese companies, the government seeks to capitalize on their expertise and technological advancements, aiming to propel the sector's growth and enhance India's healthcare ecosystem.

Mandaviya's address in Tokyo serves as a call to action for Japanese medical device manufacturers to explore the vast potential and opportunities that India offers. With its large market, supportive policies, and focus on domestic manufacturing and innovation, India presents a favorable landscape for investment and collaboration in the medical devices sector. As India continues its journey towards self-reliance in healthcare, partnerships with international players will play a vital role in driving the industry's growth and achieving its ambitious goals.


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.


© Digital Health News 2024